Cite
HARVARD Citation
Cicènas, S. et al. (2016). Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study). Lung cancer. pp. 30-37. [Online].